198 related articles for article (PubMed ID: 25229603)
1. The pharmacokinetics of dexmedetomidine administered as a constant rate infusion in horses.
Ranheim B; Risberg ÅI; Spadavecchia C; Landsem R; Haga HA
J Vet Pharmacol Ther; 2015 Feb; 38(1):93-6. PubMed ID: 25229603
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in the horse.
Rezende ML; Grimsrud KN; Stanley SD; Steffey EP; Mama KR
J Vet Pharmacol Ther; 2015 Feb; 38(1):15-23. PubMed ID: 25066475
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of dexmedetomidine administered intravenously in isoflurane-anesthetized cats.
Escobar A; Pypendop BH; Siao KT; Stanley SD; Ilkiw JE
Am J Vet Res; 2012 Feb; 73(2):285-9. PubMed ID: 22280391
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic profile and pharmacodynamic effects of romifidine hydrochloride in the horse.
Wojtasiak-Wypart M; Soma LR; Rudy JA; Uboh CE; Boston RC; Driessen B
J Vet Pharmacol Ther; 2012 Oct; 35(5):478-88. PubMed ID: 22233529
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of yohimbine following intravenous administration to horses.
Dimaio Knych HK; Steffey EP; Deuel JL; Shepard RA; Stanley SD
J Vet Pharmacol Ther; 2011 Feb; 34(1):58-63. PubMed ID: 21219345
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses.
Lankveld DP; Driessen B; Soma LR; Moate PJ; Rudy J; Uboh CE; van Dijk P; Hellebrekers LJ
J Vet Pharmacol Ther; 2006 Dec; 29(6):477-88. PubMed ID: 17083451
[TBL] [Abstract][Full Text] [Related]
9. Blood concentrations of remifentanil during and after infusion in horses anesthetized with isoflurane and dexmedetomidine.
Benmansour P; Billinsky J; Duke-Novakovski T; Alcorn J
Res Vet Sci; 2016 Aug; 107():202-206. PubMed ID: 27473996
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of dexmedetomidine, MK-467, and their combination following intravenous administration in male cats.
Pypendop BH; Honkavaara J; Ilkiw JE
J Vet Pharmacol Ther; 2016 Oct; 39(5):460-8. PubMed ID: 26896345
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Children Undergoing Ambulatory Surgery.
Pérez-Guillé MG; Toledo-López A; Rivera-Espinosa L; Alemon-Medina R; Murata C; Lares-Asseff I; Chávez-Pacheco JL; Gómez-Garduño J; Zamora Gutiérrez AL; Orozco-Galicia C; Ramírez-Morales K; Lugo-Goytia G
Anesth Analg; 2018 Sep; 127(3):716-723. PubMed ID: 29782406
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of midazolam after intravenous administration to horses.
Hubbell JA; Kelly EM; Aarnes TK; Bednarski RM; Lerche P; Liu Z; Lakritz J
Equine Vet J; 2013 Nov; 45(6):721-5. PubMed ID: 23489241
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: A clinical trial.
Song JC; Gao H; Qiu HB; Chen QB; Cai MH; Zhang MZ; Lu ZJ
PLoS One; 2018; 13(11):e0207427. PubMed ID: 30427948
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations at two dexmedetomidine constant rate infusions in isoflurane anaesthetized horses: a clinical study.
Bettembourg V; Dulgheriu D; Haga HA
Vet Anaesth Analg; 2019 Sep; 46(5):627-635. PubMed ID: 31395482
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of three escalating dexmedetomidine and lignocaine constant rate infusions in conscious horses.
Risberg A; Spadavecchia C; Ranheim B; Krontveit R; Haga HA
Vet J; 2014 Dec; 202(3):489-97. PubMed ID: 25266648
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamic effects of tolazoline following intravenous administration to horses.
Casbeer HC; Knych HK
Vet J; 2013 Jun; 196(3):504-9. PubMed ID: 23321455
[TBL] [Abstract][Full Text] [Related]
17. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine.
Weerink MAS; Struys MMRF; Hannivoort LN; Barends CRM; Absalom AR; Colin P
Clin Pharmacokinet; 2017 Aug; 56(8):893-913. PubMed ID: 28105598
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of dexmedetomidine after intranasal administration.
Iirola T; Vilo S; Manner T; Aantaa R; Lahtinen M; Scheinin M; Olkkola KT
Eur J Clin Pharmacol; 2011 Aug; 67(8):825-31. PubMed ID: 21318594
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and clinical effects of pirfenidone administered intravenously in horses.
Braim AE; Macdonald MH; Bruss ML; Stanley SD; Giri JK; Giri SN
Am J Vet Res; 2008 Jul; 69(7):952-60. PubMed ID: 18593250
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamics of xylazine administered to exercised thoroughbred horses.
Knych HK; Stanley SD; McKemie DS; Arthur RM; Kass PH
Drug Test Anal; 2017 May; 9(5):713-720. PubMed ID: 27492623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
